Celularity Inc. Class A Common Stock

$1.260
USD
Last updated on --.
24h volume214.04K
24h highest1.3300 USD
24h lowest1.2400 USD
24h Price movement-3.82%

CELU recent prices

24 Hours
-3.82%-$0.05
30 days
+64.35%+$0.5149
60 days
+73.03%+$0.555
90 days
+87.91%+$0.6152

Key data

Previous close1.3100 USD
Market cap37.92M USD
Volume214.04K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.1700 USD
Net income (FY)-91.72M USD
Revenue (FY)26.55M USD
Last report dateApr 30, 2026

About Celularity Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersFLORHAM PARK
Employees (FY)115.00
Revenue per employee (FY)230.87K USD
Net income per employee (FY)-797.53K USD
Listed onNasdaq
Official website

CELU conversion tables

CELUCELU
USDUSD
0.5 CELU0.63 USD
1 CELU1.260 USD
5 CELU6.300 USD
10 CELU12.6 USD
USDUSD
CELUCELU
0.5 USD0.39683 CELU
1 USD0.79365 CELU
5 USD3.968 CELU
10 USD7.936 CELU

FAQ

CELU is trading at $1.260, -3.82% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CELU stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CELU is currently trading at $1.260, -3.82% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CELU price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CELU's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CELU; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CELU's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Celularity Inc. Class A Common Stock's market cap is currently 37.92M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume214.04K
24h highest1.3300 USD
24h lowest1.2400 USD
24h Price movement-3.82%
CELUCELU
USDUSD
Start trade with CELU Perpetual